Welcome to Psoriasis Causes & Treatment Guide
Latest Information On Psoriasis News
Treatment Approval - a Step Forward in Managing Severe Psoriasis in ... - EIN News
TAPLOW, England, January 8 /PRNewswire/ -- Wyeth Pharmaceuticals has today announced that Enbrel(R) (etanercept) is approved for the treatment of chronic severe plaque psoriasis in children aged 8 years and above, making it the only biologic ...
Read more...Wyeth Europa: European Commission Approval Makes Enbrel(R) First and ... - PressePortal.de
Maidenhead, England (ots/PRNewswire) - - For the First Time, Children and Adolescents in Europe With Psoriasis are now Able to Benefit From Same Efficacy and Disease Control as Adults The European Commission today granted marketing authorisation of ...
Read more...Provectus Pharmaceuticals Updates Shareholders on 2008 Accomplishments - Phramalive.com
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Jan 6, 2009 - Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, reports on its clinical and corporate accomplishments for 2008 in a letter to ...
Read more...Idera Pharmaceuticals Announces Publication of Studies on Chemistry of ... - Earthtimes
CAMBRIDGE, Mass. - (Business Wire) Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the publication of studies on the chemistry of novel compounds that have been shown to act as antagonists for Toll-like Receptors (TLR) 7 and 9. These ...
Read more...Quinnova Pharmaceuticals, Inc. Launches Salvax (Hydrating Topical Foam ... - Earthtimes
NEWTOWN, Pa. - (Business Wire) Quinnova Pharmaceuticals, Inc. announced today the launch of Salvax (Hydrating Topical Foam) Rx for the treatment of hyperkeratotic conditions such as psoriasis, keratosis pilaris, and xerosis. Salvax (Hydrating Topical ...
Read more...



